Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

A Multicenter, Open-label, Expanded Access Study of KTE-X19 for the Treatment of Subjects with Relapsed/Refractory B-Cell Malignancies (ZUMA-18)

Lymphoma

Disease Sites: Lymphoma

Phase: II

Investigator: Oluwole, Olalekan

NCTID: NCT04162756

Protocol No: VICCBMT19124

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)